Volume 32, Issue 4 e12922
Therapeutic Hotline: Short Paper

Case series of post-purpuric darkness on the periorbital area after aesthetic surgery

Sang Ju Lee

Sang Ju Lee

Yonsei Star Skin & Laser Clinic, Seoul, South Korea

Sang Ju Lee and Ga Ram Ahn contributed equally to this study.Search for more papers by this author
Ga Ram Ahn

Ga Ram Ahn

Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea

Sang Ju Lee and Ga Ram Ahn contributed equally to this study.Search for more papers by this author
Hyun Jung Kwon

Hyun Jung Kwon

Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea

Search for more papers by this author
Kui Young Park

Corresponding Author

Kui Young Park

Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea

Correspondence

Kui Young Park, Department of Dermatology, Chung-Ang University Hospital, 224-1 Heukseok-dong, Dongjak-ku, Seoul 156-755, South Korea.

Email: [email protected]

Search for more papers by this author
Beom Joon Kim

Beom Joon Kim

Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea

Search for more papers by this author
First published: 12 April 2019
Citations: 2

Abstract

Periorbital hyperpigmentation (POH) is a common condition encountered in dermatology practice. POH is caused by various exogenous and endogenous factors including excessive pigmentation, postinflammatory hyperpigmentation (PIH) secondary to eczema, periorbital edema, excessive vascularity, and aging. Recently, we have experienced several patients who complained of POH with an unusual pattern. Their pigmented lesions had several features in common. The pigmentation occurred bilaterally after aesthetic surgery involving the periorbital region. Periorbital post-purpuric darkness should be distinguished from common POH. Practitioners should ask patients about history of prior aesthetic surgery and make their patients aware that the dark colors are composed of various pigments such as hemosiderin, which make treatment troublesome. Conservative management with expectations for gradual spontaneous regression or laser therapy with multiple wavelengths including 1,064-nm laser for PIH and 650 or 694-nm laser targeting heme-derived pigments may be considered as treatment options.

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.